The Relationship between Circulating ANGPTL8Betatrophin Concentrations and Adult Obesity: A Meta-Analysis

Joint Authors

Ye, Jingjing
Qin, Yu
Wang, Dong
Yang, Ling
Yuan, Guoyue

Source

Disease Markers

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-7, 7 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-10-22

Country of Publication

Egypt

No. of Pages

7

Main Subjects

Diseases

Abstract EN

In this study, we evaluated the relationship between circulating betatrophin levels and obesity.

Obesity is a common public health problem that is increasing globally.

Betatrophin, a newly identified protein, is predominantly expressed in white and brown fat tissues and in the liver.

Growing evidence suggests that betatrophin plays a pivotal role in metabolism, including the synthesis and degradation of lipids in cells, and adipocyte differentiation.

Previous studies have assessed the association between circulating betatrophin levels and obesity; however, this relationship remains unclear.

Therefore, our study is aimed at examining the impact of betatrophin on obesity using a meta-analysis of the current evidence.

We performed a meta-analysis to quantify the relationship between betatrophin levels and obesity.

A literature search was conducted through the EMBASE, Web of Science, and MEDLINE databases.

Retrieved studies were screened, without any language restrictions to identify relevant literature published up to December 2018.

Observational studies, in which the association between circulating concentrations of betatrophin and obesity was evaluated, were considered suitable for the systematic review.

Of the 65 manuscripts retrieved, 9 datasets from 6 studies, involving 681 participants, detected an association between circulating betatrophin and obesity.

Circulating betatrophin levels of obese subjects were higher than those of nonobese subjects (random−effects weighted mean difference WMD=0.250 μg/mL, 95% CI: 0.048–0.451, I2=94.8%, p=0.015), yet with significant between-study heterogeneity.

This heterogeneity appeared to be modified by glycemic status but not by age, the ELISA kits used, sample source, or body mass index.

The high circulating betatrophin concentration may directly increase the risk of obesity in adults.

Betatrophin may serve as a therapeutic target for obesity in adults.

American Psychological Association (APA)

Ye, Jingjing& Qin, Yu& Wang, Dong& Yang, Ling& Yuan, Guoyue. 2019. The Relationship between Circulating ANGPTL8Betatrophin Concentrations and Adult Obesity: A Meta-Analysis. Disease Markers،Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1147325

Modern Language Association (MLA)

Ye, Jingjing…[et al.]. The Relationship between Circulating ANGPTL8Betatrophin Concentrations and Adult Obesity: A Meta-Analysis. Disease Markers No. 2019 (2019), pp.1-7.
https://search.emarefa.net/detail/BIM-1147325

American Medical Association (AMA)

Ye, Jingjing& Qin, Yu& Wang, Dong& Yang, Ling& Yuan, Guoyue. The Relationship between Circulating ANGPTL8Betatrophin Concentrations and Adult Obesity: A Meta-Analysis. Disease Markers. 2019. Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1147325

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1147325